Serum arginase as breast cancer marker

Grzegorz Luboiński; Iwona Szkop; Janina Kamińska; Zofia Porembska

Abstract

1/2001 vol. 5

Serum arginase as breast cancer marker

Grzegorz Luboiński

,

Iwona Szkop

,

Janina Kamińska

,

Zofia Porembska

Współcz Onkol (2001) vol. 5, 1 (14-16)

Online publish date: 2003/07/09

View full text

AMA

Luboiński G, Szkop I, Kamińska J, Porembska Z. Serum arginase as breast cancer marker. Contemporary Oncology/Współczesna Onkologia. 2001;5(1):14-16.

APA

Luboiński, G., Szkop, I., Kamińska, J., & Porembska, Z. (2001). Serum arginase as breast cancer marker. Contemporary Oncology/Współczesna Onkologia, 5(1), 14-16.

Chicago

Luboiński, Grzegorz, Iwona Szkop, Janina Kamińska, and Zofia Porembska. 2001. "Serum arginase as breast cancer marker". Contemporary Oncology/Współczesna Onkologia 5 (1): 14-16.

Harvard

Luboiński, G., Szkop, I., Kamińska, J., and Porembska, Z. (2001). Serum arginase as breast cancer marker. Contemporary Oncology/Współczesna Onkologia, 5(1), pp.14-16.

MLA

Luboiński, Grzegorz et al. "Serum arginase as breast cancer marker." Contemporary Oncology/Współczesna Onkologia, vol. 5, no. 1, 2001, pp. 14-16.

Vancouver

Luboiński G, Szkop I, Kamińska J, Porembska Z. Serum arginase as breast cancer marker. Contemporary Oncology/Współczesna Onkologia. 2001;5(1):14-16.

In 150 women admitted with breast pathology, serum arginase level and serum ASPAT, ALAT, LDH, GGTP, IL-6 and Ca 15,3 were analysed. Arginase was found to be a most sensitive and cheapest breast cancer marker. Evaluation of arginase for monitoring of disease and effectiveness of treatment needs further investigation.

Keywords

breast cancer, arginase, cancer markers

Abstract

Serum arginase as breast cancer marker

Keywords

Share

Coverage in

Indexed in

Integrated with

Editorial Policies